Angel Colon
About Angel Colon
Angel Colon serves as an independent director of Horizon Space Acquisition I Corp. (HSPO) and was re‑elected as Class I director on December 20, 2024; his Class I term runs to the 2027 annual meeting . He has a BS in International Business from St. John Fisher College and holds FINRA Series 6, 7, 24, 63, and 65 licenses, reflecting compliance and capital markets expertise . Colon’s biography highlights roles in investment advisory and capital markets (Entoro Wealth/Entoro Capital) and service on a public board (Sentage Holdings Inc.), underscoring regulatory and financial governance credibility .
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| Entoro Wealth LLC | Chief Compliance Officer | Since Jul 2020 | Compliance oversight and policy leadership |
| Entoro Capital LLC | Managing Director | Since Jun 2019 | Strategic advisory; affiliates with FINRA-registered broker Entoro Securities LLC |
| Andean Farm and Pharma Corp. | Financial advisor/consultant | Since Dec 2018 | Risk mitigation and financial planning consultancy |
| Bronson Resource Limited | Financial advisor/consultant | Since Dec 2018 | Risk mitigation and financial planning consultancy |
| Turing Funds, LLC | Managing Member | Since Jul 2017 | Business services leadership |
| NY Capital Management Group, LLC | Managing Member | Since Jan 2017 | Investment management leadership |
| Vega Management Advisors, LLC; Vega Management Investments, LLC | Managing Member | Oct 2018 – Feb 2020 | Investment management responsibilities |
External Roles
| Organization | Role | Tenure | Notes |
|---|---|---|---|
| Sentage Holdings Inc. (Nasdaq: SNTG) | Independent Director | Since Jul 2021 | Holding company providing financial services in the PRC |
Board Governance
- Board classification: HSPO board is split into three classes; Colon is Class I with term expiring at the 2027 AGM .
- Re‑election history: Colon was re‑nominated and approved for re‑election as Class I director at the Dec 20, 2024 extraordinary meeting .
- Special Committee: A Special Committee was formed Nov 1, 2023 to evaluate a potential business combination; members were independent directors Angel Colon, Mark Singh, and Rodolfo José González Cáceres .
- Audit committee: Responsibilities are described (appointing, compensating, and pre‑approving auditor services), but proxy did not specify committee membership in the 2025 filing .
- Independence: Colon is explicitly described as an “independent director” of HSPO .
- Geographic dispersion: Management/directors span China, U.S., and Colombia, potentially complicating enforcement of U.S. civil liabilities; PRC enforcement challenges are noted at a board-level risk context .
Other Directorships & Interlocks
| Company | Role | Potential Interlocks/Considerations |
|---|---|---|
| Sentage Holdings Inc. (SNTG) | Independent Director | Operates in PRC; HSPO has considered PRC targets and notes PRC regulatory/enforcement risks; no specific interlock or related party transaction disclosed with HSPO . |
Expertise & Qualifications
- Capital markets and compliance credentials via Entoro Wealth/Capital leadership and FINRA licenses (Series 6/7/24/63/65) .
- International business education (BS, St. John Fisher College) .
- Advisory experience across agriculture/pharma and resources, supporting risk and strategic financial planning .
Equity Ownership
| Metric | Q2 2023 | Q4 2023 | Q3 2024 | Q3 2025 |
|---|---|---|---|---|
| Shares beneficially owned | 8,000 | 8,000 | 8,000 | 9,000 |
| % of shares outstanding | <1% (“Less than one percent”) | <1% (“Less than one percent”) | <1% (“Less than one percent”) | <1% (“Less than one percent”) |
| Total shares outstanding (reference) | 9,210,750 | 8,647,971 | — | 4,168,739 |
| Ownership detail | Founder Shares transferred pre‑IPO (8,000) | Founder Shares held (8,000) | Founder Shares held (8,000) | Founder Shares held (9,000) |
| Founder share cost basis | ~$0.0145 per share (independent directors) |
Independent directors, including Angel Colon, waived redemption rights on founder shares; these become worthless if no business combination, aligning them economically to deal completion .
Governance Assessment
- Alignment and Incentives: Colon’s founder shares (low-cost equity) and waiver of redemption rights create strong incentives to complete a business combination; HSPO explicitly highlights insider interests and potential conflicts, including independent directors’ founder shares becoming worthless absent a deal .
- Board Control and Sponsor Influence: The Sponsor held ~50.20% of shares outstanding as of Oct 6, 2025, signaling concentrated control; the CEO/CFO/Chair is also sole director of the Sponsor, increasing affiliated influence over board processes .
- Committee Effectiveness: Colon served on a three‑member Special Committee of independent directors to evaluate the Shenzhen Squirrel transaction, indicating active participation in deal governance .
- Regulatory/Enforcement Context: HSPO notes PRC enforcement challenges and cross‑border director locations, which could impede U.S. civil liability enforcement post‑combination, underscoring the importance of robust governance safeguards .
RED FLAGS
- Founder share economics: Very low-cost founder shares and non‑redeemable status create a structural incentive to approve transactions even if marginal; HSPO flags this as a conflict for insiders and independent directors (including Colon) .
- Sponsor dominance: Sponsor’s ~50.20% stake and its control by the CEO/CFO/Chair raise independence concerns at a board level .
- Cross‑border enforcement risk: Disclosed difficulty enforcing U.S. judgments against officers/directors outside the U.S., particularly in a PRC context .
Committee Assignments
| Committee | Role | Notes |
|---|---|---|
| Special Committee (Business Combination) | Member | Formed Nov 1, 2023 to review and evaluate LOI/proposed business combination with Shenzhen Squirrel; comprised solely of independent directors (Colon, Singh, González Cáceres) |
| Audit Committee | — | Responsibilities disclosed (auditor oversight, pre‑approval of services); membership not specified in the 2025 proxy |
Independence, Tenure, Engagement
- Independence: Identified as an independent director of HSPO .
- Tenure and classification: Re‑elected Class I director on Dec 20, 2024; Class I term to 2027 AGM .
- Attendance: Not disclosed in reviewed proxies.
- Engagement: Participation on Special Committee for deal review indicates active governance role .
Potential Conflicts or Related-Party Exposure
- Insider Interests: HSPO explicitly discloses insider interests including independent directors’ founder shares; Sponsor founder/private shares and extension financing arrangements are outlined (Extension Notes to Sponsor and Squirrel) .
- No specific Item 404 transactions disclosed involving Colon in reviewed proxies; insider financing referenced pertains to Sponsor and Squirrel entities .
Re‑Election and Voting Context
- The board recommended FOR Colon’s re‑election in 2024 and recommended FOR related proposals (MAA/Trust Amendments) to facilitate transaction timelines and extensions .
- In 2025, board classification shows Colon as Class I (term to 2027), while Class II re‑elections focused on other directors .